Mathew Simcock

Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care—SAKK 33/99

Jakob Passweg, Aristoteles Giagounidis, Mathew Simcock et al. · Journal of Clinical Oncology · 2010 · 189 citations

Medicine, Hematology, Immunology +17

Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma

Meletios Α. Dimopoulos, Antonio Palumbo, Paolo Corradini et al. · Blood · 2016 · 162 citations · Full text

Medicine, Hematology, Oncology +15

Tenofovir Use is associated with a Reduction in Calculated Glomerular Filtration Rates in the Swiss HIV Cohort Study

Christoph A. Fux, Mathew Simcock, Marcel Wolbers et al. · Antiviral Therapy · 2007 · 136 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

Galactomannan Does Not Precede Major Signs on a Pulmonary Computerized Tomographic Scan Suggestive of Invasive Aspergillosis in Patients with Hematological Malignancies

Maja Weisser, Caitlin R. Rausch, A. Droll et al. · Clinical Infectious Diseases · 2005 · 94 citations · Full text

Veterinary Medicine, Hematology, Infectious Diseases +16

Continuous Sunitinib Treatment in Patients with Advanced Hepatocellular Carcinoma: A Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) Multicenter Phase II Trial (SAKK 77/06)

Dieter Koeberle, Michael Montemurro, Panagiotis Samaras et al. · The Oncologist · 2010 · 92 citations · Full text

Medicine, Oncology, Pharmacology +17